How many mL and units is a testosterone cypionate dose?
Draw to
unitsmL
0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe
The draw is the dose divided by the concentration printed on the vial, in mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.
Save to Milligram
Open in Milligram shows once the calculator has a result.
Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.
Open in Milligram is off while the draw is under one unit. Check the dose and its unit.
Open in Milligram adds Testosterone Cypionate and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.
The Depo-Testosterone label gives 50 to 400 mg every two to four weeks for replacement in the hypogonadal male, and says the dosage varies with the age, sex and diagnosis of the patient and is adjusted to the patient's response and the appearance of adverse reactions.1
The guide's example
125 mg of Testosterone Cypionate at 250 mg/mL is 0.5 mL, the 50 mark on a U-100 syringe.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Concentration | Draw per dose |
|---|---|
| 250 mg/mL37% set up13 | 250 mg/mL: 50 mg is 0.2 mL, the 20 mark, 100 mg is 0.4 mL, the 40 mark, 200 mg is 0.8 mL, the 80 mark |
| Arithmetic only, no logged share | |
| 200 mg/mL | 200 mg/mL: 50 mg is 0.25 mL, the 25 mark, 100 mg is 0.5 mL, the 50 mark, 200 mg is 1 mL, the 100 mark |
mL and syringe units per dose
The Depo-Testosterone label lists 100 mg/mL and 200 mg/mL strengths in cottonseed oil, and the 200 mg/mL strength comes in 1 mL and 10 mL vials.1 Of the people who logged a strength, 37% logged 250 mg/mL, and of the people who set up a vial, 24% set up 2,000 mg in 10 mL.13 None of the three labels read lists that logged strength: they give 100 mg/mL and 200 mg/mL, or 200 mg/mL alone.123 At 200 mg/mL, a 100 mg dose is 0.5 mL, which is 50 units on a U-100 syringe.14 At 100 mg/mL, the Depo-Testosterone label's lower strength, a 50 mg dose is 0.5 mL (50 units) and a 100 mg dose is 1 mL (100 units), the whole of a 1 mL U-100 syringe.14 The Azmiro label gives its 200 mg/mL strength as a 1 mL single-dose vial or a 1 mL prefilled syringe, says the prefilled syringe is only for 200 mg doses and is given by a healthcare professional only, and gives other doses from the single-dose vial.3 The Depo-Testosterone label describes testosterone cypionate itself as a crystalline powder that is insoluble in water and soluble in vegetable oils, and lists the product as a solution in benzyl benzoate and cottonseed oil; no label read gives a mixing or water step.1
125 mg of Testosterone Cypionate at 250 mg/mL is 0.5 mL, the 50 mark on a U-100 syringe.
100 mg of Testosterone Cypionate at 200 mg/mL is 0.5 mL, the 50 mark on a U-100 syringe.
What a unit on the syringe is
A U-100 syringe holds 100 units in every mL, and the FDA gives 5 units on a 1 mL U-100 syringe as 0.05 mL.45 Of the people who logged a unit, 94% logged mg and 4% IU.13 The Depo-Testosterone and Azmiro labels give the dose in mg, not in IU or in syringe units.13
Dose and schedule on labels and in trials
The Azmiro label gives 50 mg to 400 mg every two to four weeks as a deep intramuscular injection in the gluteal muscle, for replacement therapy in males with a deficiency or absence of their own testosterone, and says to individualize the dose and schedule based on the patient's age, diagnosis, response to treatment and adverse reactions.3 No label read gives a dose for women: Depo-Testosterone is for replacement in the male, Azmiro says it is not indicated in females, and the trials read that gave a dose to people not male at birth were in transgender men.13678
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Sih et al., 19979 | 200 mg every two weeks, against placebo | 17 older hypogonadal men on testosterone, fifteen on placebo | 12 months |
| Choi et al., 202210 | 100 mg weekly into muscle, against 100 mg weekly of subcutaneous enanthate by autoinjector | 234 hypogonadal men across both groups | 12 weeks |
| Okano et al., 20258 | 100 mg every two weeks into muscle, against stopping testosterone | Forty-three transgender men aged 18 to 40 with erythrocytosis completed | 3 months |
| Sanyal et al., 20267 | 50 mg weekly under the skin, of what the paper calls an aqueous solution (every label read gives cypionate in oil) | 22 transgender men, retrospective cohort | 6 months |
| Bi et al., 201811 | 100, 250 or 500 mg weekly, randomized by dose group, double-blind | Thirty-one healthy men | 14 weekly injections |
| Pope et al., 200012 | Doses rising to 600 mg a week, against placebo in a randomized crossover | 56 men aged 20 to 50 | 6 weeks on each, 6 weeks apart |
Of the people who logged a dose, 10% set up 250 mg, 9% 50 mg, 8% 100 mg and 7% 200 mg.13
Route
The Depo-Testosterone label gives intramuscular use only, deep in the gluteal muscle.1 Of the people who logged a route, 84% logged muscle and 15% under the skin.13 In a 14-person open-label crossover pilot of transgender men already on intramuscular testosterone, Wilson and colleagues (2018) found comparable exposure over 3 weeks of intramuscular and then 8 weeks of subcutaneous cypionate or enanthate (mean AUC 1.7 ± 0.6 nmol·days/L/mg subcutaneous against 1.9 ± 0.6 nmol·days/L/mg intramuscular), with wide variability.6
Storage
The Depo-Testosterone and Cipla labels give 20° to 25°C and both say to protect from light.12 The Azmiro label gives 15°C to 25°C, with excursions permitted to 2°C to 30°C, and says to store it in its carton to protect it from light.3 None of the three labels read gives a period after the first puncture of a vial, and none says to refrigerate.123
Frequently asked questions
What goes wrong when mg, mL and units are mixed up?
The FDA says confusion between milliliters, milligrams and units may have contributed to dosing errors with compounded semaglutide, a different drug.5 In most of the reports, patients drew up more than the prescribed dose of semaglutide from a multiple-dose vial and took five to 20 times the intended dose; in several reports, patients directed to administer 5 units from a vial administered 50 units instead.5
- Testosterone cypionateHalf-life, strengths and studies.
- Testosterone cypionate calculatorVolume and syringe marks.
- Testosterone estersThe class.
- TRT guideReplacement therapy overview.
- Testosterone enanthate dosageThe same figures for enanthate.
- Cypionate vs enanthateSide by side.
- Testosterone injection sitesWhere injections are logged.
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- DailyMed (Pharmacia & Upjohn, Pfizer label). Depo-Testosterone (testosterone cypionate) injection, USP CIII, prescribing information (revised October 2025). 2025. dailymed.nlm.nih.gov
- DailyMed (Cipla USA label). Testosterone Cypionate Injection, USP 200 mg/mL prescribing information. dailymed.nlm.nih.gov
- DailyMed (Azurity Pharmaceuticals label). AZMIRO (testosterone cypionate) injection prescribing information. dailymed.nlm.nih.gov
- US Food and Drug Administration (device clearance). FDA 510(k) summary K233794, single-use insulin syringe U-40 and U-100. 2024. accessdata.fda.gov
- US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. 2024. fda.gov
- American Journal of Health-System Pharmacy (Wilson, Kiang, Ensom), PubMed abstract. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: a pilot study. 2018. eutils.ncbi.nlm.nih.gov
- Indian Journal of Endocrinology and Metabolism. Efficacy of fixed low-dose weekly subcutaneous testosterone self-administration in transgender male patients in India. 2026. ebi.ac.uk
- Journal of Sexual Medicine (PubMed abstract). Effect of 100 mg of testosterone cypionate in trans men with erythrocytosis: a randomized controlled pilot study. 2025. eutils.ncbi.nlm.nih.gov
- Journal of Clinical Endocrinology and Metabolism (PubMed abstract). Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. 1997. eutils.ncbi.nlm.nih.gov
- Journal of Urology (Choi et al), PubMed abstract. Comparison of outcomes for hypogonadal men treated with intramuscular testosterone cypionate versus subcutaneous testosterone enanthate. 2022. eutils.ncbi.nlm.nih.gov
- CPT: Pharmacometrics and Systems Pharmacology (PubMed abstract). Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects. 2018. eutils.ncbi.nlm.nih.gov
- Archives of General Psychiatry (PubMed abstract). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. 2000. eutils.ncbi.nlm.nih.gov
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted